A few months after the American Chemical Society won its lawsuit against the pirate site, the game of virtual whack-a-mole continues.
Although the popular blacklist of predatory publishers is gone, the suspect journals they produce are not.
August 15, 2017|
ISTOCK, EGUDINKAMore new scientific journals were launched in the last decade than the number that came into existence up until 2007. This uptick likely owes to the academic competitiveness, and hence difficulty, of publishing in conventional scientific journals as well as the ease of launching an online journal. While an increased opportunity to present one's scientific work is a positive trend to which we are not opposed, something new has emerged: pseudo-scientific journals that are launched for mere financial gain.
Not surprisingly, predatory journals have journal names that are almost indistinguishable from legitimate journals, making it very difficult to differentiate the two merely by name. For example, is the International Journal of Rheumatology a real journal, or a fake one? What about these two: Blood vs. The Journal of Blood?
For example, when a journal is willing to publish a text regardless of its contents, when a journal sends automated, computer-generated letters inviting recipients to join its editorial board, and occasionally to even serve as a guest editor, it is unlikely that the scientific community benefits. One particularly irritating spinoff from this new practice is an endless stream of spam emails soliciting scientists to contribute manuscripts in fields of science irrelevant to their work. In our own experience, more than 50 percent of all spam we received consists of emails from predatory journals.
What is a predatory journal? University of Colorado, Denver, librarian Jeffrey Beall categorized open-access publishers as being predatory based on 52 predefined criteria including aggressiveness, unsolicited emailing, using a common template to quickly create each journal’s home page, using false claims of being indexed in legitimate abstracting and indexing services, and many more.
In a recent letter to The American Journal of Medicine, we highlighted the unfortunate closure of a unique website called Beall's List of Predatory Journals. Aside from this list, Beall’s website provided an open communication between researchers through which they shared their experiences dealing with such entities. Some have suggested that financial threats made against Beall by open-access predatory publishers (perhaps those already on the list) prompted the closure.
We urge the scientific community to collaborate on defining measurable criteria for what a predatory journal is, along the lines of Beall's list, and to launch a platform that would allow the scientific community to differentiate legitimate journals from predatory ones, a platform that will be immune to the pressure exerted from such publishers. Perhaps the International Committee of Medical Journal Editors, a group of general medical journal editors whose participants meet annually and fund their own work on the recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals could overlook such an initiative.
Michael Mimouni is an ophthalmologist and researcher at Rambam Health Care Campus and the Bruce Rappaport School of Medicine Technion Israel Institute of Technology in Haifa, Israel; Eytan Z. Blumenthal is the director of the Department of Ophthalmology at Rambam Health Care Campus and a professor at the Bruce Rappaport School of Medicine Technion Israel Institute of Technology in Haifa, Israel; Eyal Braun is the director of the Department of Internal Medicine H at Rambam Health Care Campus and a professor at the Bruce Rappaport School of Medicine Technion Israel Institute of Technology; Francis B. Mimouni is a professor in the Department of Neonatology at Shaare Zedek Medical Center in Jerusalem and the Sackler Faculty of Medicine at Tel Aviv University; Daniel Mimouni is a professor in the Department of Dermatology at Beilinson Hospital in Petach Tikva and at the Sackler Faculty of Medicine at Tel Aviv University
August 16, 2017
I think the "whitelist" approach (see https://www.the-scientist.com/?articles.view/articleNo/49903/title/On-Blacklists-and-Whitelists/) is better than the blacklist approach. There are a limited number of serious, honest publicaitons to put on a whitelist, while creating a blacklist is an eternal project.
August 16, 2017
Perhaps we do need a replacement for Beall's list. But if so, we should ensure that it is based on accurate criteria for what constitutes a predatory publisher, rather than his transparent anti-open-access ideology. See http://triplec.at/index.php/tripleC/article/view/525/514 for his own words, ironically published in an OA journal.
August 16, 2017
The authors might be interested in this articleU.S. company launches a new blacklist of deceptive academic journals
August 16, 2017
There are many levels of predatory behaviour. Many articles written by people who never granted copyright to the publisher several decades ago are now being sold by publishers who have "appropriated" them. This is something that the authors never would have intended. Some journals that run under the name of a private society have been sold to for-profit publishers. In my opinion anything less than open-access and author retention of copyright is a form of predatory behaviour. This predation is engaged in by many of the so-called prestigious journals. Blacklisting is mostly a way to protect the financial position of the most successful predators.
August 16, 2017
I agree 'a' whitelist is a good idea, and maybe less contentious than blacklists, and not just in Medicine, but in every field. It might be hard to get governments to do this, because that would seem to be unfairly favouring one publisher over another. But scientific societies could easily do so, in the same way that the AMA and ADA approve medical treatments.
I support open access, and agree with Daniel Dvorkin that John Beall's article http://triplec.at/index.php/tripleC/article/view/525/514 is extreme, but I do think he makes some very good points too. I don't think open access needs a 'holier than thou' approach to policy, it is surviving quite well without it.
Contrary to what Beall says, there are very good reasons why governments funding research would prefer to pay up front for publication rather than have the research they fund hidden behind paywalls. Contrary to what Beall says, I think scientists who do interesting work mostly benefit from open access by having their work more widely read. Even readers whose institutions subscribe are be more productive and read more papers more quickly without paywalls, as anyone who has tried to access online literature away from their usual institution will know (at home, or while travelling, for instance).